Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer

NCT05620134 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer
Tumor, Solid
Advanced Solid Tumor
Metastatic Cancer
Melanoma
Colorectal Cancer
Non-small Cell Lung Cancer
Small-cell Lung Cancer
Urothelial Carcinoma
Squamous Cell Carcinoma of Head and Neck
Luminal Breast Cancer
Triple Negative Breast Cancer
Clear Cell Renal Cell Carcinoma
Papillary Renal Cell Carcinoma
Gastric Adenocarcinoma
GastroEsophageal Cancer
Squamous Cell Carcinoma Skin
Pancreatic Adenocarcinoma
Hepatocellular Carcinoma
Colorectal Adenocarcinoma
Epithelial Ovarian Cancer
Thyroid Cancer

Interventions

DRUG: JK08
DRUG: Pembrolizumab
DRUG: Lenvatinib Pill

Sponsor

Salubris Biotherapeutics Inc